Edesa Biotech, Inc. — Balance Sheet Charts
34 snapshots of history · ending 2021-09-30 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↑+35.5% +$4M
$15M
Current Assets↑+49.2% +$4M
$12M
Cash & Equivalents↑+8.7% +$626K
$8M
ST Investments↓-68.7% -$1M
$500K
Receivables
$56K
Inventory↓-67.2% -$160K
$78K
Net PPE↑+1.2% +$174
$15K
Intangibles↓-4.1% -$101K
$2M
Total Liabilities↓-7.7% -$128K
$2M
Current Liabilities↓-4.7% -$71K
$1M
Stockholders Equity↑+96.9% +$6M
$13M
Retained Earnings↓-101.7% -$13M
$-26M
Operating Lease ROU Asset↓-39.6% -$63K
$97K
Operating Lease Liability↓-39.5% -$65K
$99K
Operating Lease CostNEW↓-63.4% -$36.19B
$20.89B
Gross PP&E↑+21.1% +$8K
$49K
Accumulated Depreciation↑+32.6% +$8K
$34K
Inventory Raw Materials↑+43.6% +$15K
$51K
Inventory WIP↑+116.8% +$81K
$150K
Inventory Finished Goods↓-57.1% -$58K
$43K
Edesa Biotech, Inc. — Equity RollforwardNEW
Per-period stockholders' equity flows + ending balances by component, sourced from the issuer's 10-K dimensional XBRL on us-gaap:StatementEquityComponentsAxis. Positive flows (Net Income / OCI / SBC / Stock Issuance) above the axis; negative flows (Dividends / Buybacks / Tax Withholding) below. Net change in equity per period = sum of bars.
Common + APIC
$69.3M
↑ 13.9%
Retained Earnings
−$65.9M
↓ 12.5%
AOCI
−$165.8K
↑ 31.7%
Treasury Stock
—
NCI
—
Total Equity
—